These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10067301)

  • 1. [Blood group isoantigens in transitional cell carcinoma of the urinary bladder].
    Tsushima T
    Nihon Hinyokika Gakkai Zasshi; 1999 Jan; 90(1):5-11. PubMed ID: 10067301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular markers in the diagnosis and prognosis of bladder cancer.
    Lange PH; Limas C
    Urology; 1984 Apr; 23(4 Suppl):46-54. PubMed ID: 6369720
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of blood group antigens in bladder cancer: current concepts.
    Sheinfeld J; Reuter VE; Fair WR; Cordon-Cardo C
    Semin Surg Oncol; 1992; 8(5):308-15. PubMed ID: 1462102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS; Miller AW; Coon JS
    Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
    [No Abstract]   [Full Text] [Related]  

  • 10. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
    El Adl MM; Yamase HT; Nieh PT; Mostofa AS; Hinz CF; Walzak MP
    J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single cell suspension of human bladder mucosa. Possible use in quantitating ABO(H) isoantigens in transitional cell carcinoma of bladder.
    Srinivas V; Hansen PA; Kiruluta HG
    Urology; 1982 Dec; 20(6):608-10. PubMed ID: 6758284
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of expression of carbohydrate blood group antigens.
    Watkins WM; Greenwell P; Yates AD; Johnson PH
    Biochimie; 1988 Nov; 70(11):1597-611. PubMed ID: 3149525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of an assessment of ABH(0) isoantigens and Thomsen-Friedenreich (TF) antigen expression in patients with urinary bladder tumours.
    Dobrowolski ZF; Duś D; Hałasa J; Radzikowski C
    Int Urol Nephrol; 1995; 27(4):395-404. PubMed ID: 8586511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H; Nasu Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
    Yamada T; Fukui I; Yokokawa M; Oshima H
    Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    Decenzo JM; Howard P; Irish CE
    J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO, MNSs and rhesus blood groups in bladder cancer.
    Cartwright RA; Adib R; Appleyard I; Glashan RW; Richards B; Robinson MR; Sunderland E; Barham-Hall D
    Br J Urol; 1983 Aug; 55(4):377-81. PubMed ID: 6411162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.